187 related articles for article (PubMed ID: 36994896)
1. Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24-year study from Turkey.
Özkaya E; Keskinkaya Z; Babuna Kobaner G
Contact Dermatitis; 2023 Jul; 89(1):37-45. PubMed ID: 36994896
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis caused by topical ophthalmic medications: Keep an eye on it!
Gilissen L; De Decker L; Hulshagen T; Goossens A
Contact Dermatitis; 2019 May; 80(5):291-297. PubMed ID: 30629291
[TBL] [Abstract][Full Text] [Related]
3. Topical eye medications causing allergic contact dermatitis.
Ahlström MG; Skov L; Heegaard S; Zachariae C; Garvey LH; Johansen JD
Contact Dermatitis; 2023 Apr; 88(4):294-299. PubMed ID: 36382619
[TBL] [Abstract][Full Text] [Related]
4. A Patch Testing Initiative for the Investigation of Allergic Contact Dermatitis in a UK Allergy Practice: A Retrospective Study.
Watts TJ; Watts S; Thursfield D; Haque R
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):89-95. PubMed ID: 30201159
[TBL] [Abstract][Full Text] [Related]
5. Allergic and non-allergic periorbital dermatitis: patch test results of the Information Network of the Departments of Dermatology during a 5-year period.
Herbst RA; Uter W; Pirker C; Geier J; Frosch PJ
Contact Dermatitis; 2004 Jul; 51(1):13-9. PubMed ID: 15291826
[TBL] [Abstract][Full Text] [Related]
6. Patch test results of the European baseline series among 1309 patients in Turkey between 2013 and 2019.
Boyvat A; Kalay Yildizhan I
Contact Dermatitis; 2021 Jan; 84(1):15-23. PubMed ID: 32618364
[TBL] [Abstract][Full Text] [Related]
7. Patch test results in 542 patients with suspected contact dermatitis in Turkey.
Akasya-Hillenbrand E; Ozkaya-Bayazit E
Contact Dermatitis; 2002 Jan; 46(1):17-23. PubMed ID: 11918582
[TBL] [Abstract][Full Text] [Related]
8. Occupational dermatitis in health care workers evaluated for suspected allergic contact dermatitis.
Kadivar S; Belsito DV
Dermatitis; 2015; 26(4):177-83. PubMed ID: 26172487
[TBL] [Abstract][Full Text] [Related]
9. Contact sensitivity to preservatives in Turkey.
Boyvat A; Akyol A; Gürgey E
Contact Dermatitis; 2005 Jun; 52(6):329-32. PubMed ID: 15932584
[TBL] [Abstract][Full Text] [Related]
10. Periorbital contact sensitization.
Landeck L; Schalock PC; Baden LA; Gonzalez E
Am J Ophthalmol; 2010 Sep; 150(3):366-370.e2. PubMed ID: 20541737
[TBL] [Abstract][Full Text] [Related]
11. Periorbital dermatitis in 4779 patients - patch test results during a 10-year period.
Landeck L; John SM; Geier J
Contact Dermatitis; 2014 Apr; 70(4):205-12. PubMed ID: 24325408
[TBL] [Abstract][Full Text] [Related]
12. Environmental contact factors in eczema and the results of patch testing Chinese patients with a modified European standard series of allergens.
Li LF; Guo J; Wang J
Contact Dermatitis; 2004 Jul; 51(1):22-5. PubMed ID: 15291828
[TBL] [Abstract][Full Text] [Related]
13. The Value of Patch Testing With Shoe Material Samples in Patients Suspected of Shoe Allergic Contact Dermatitis.
Boonchai W; Wongdama S; Kumpangsin T; Bunyavaree M; Pruksaeakanan C; Chaiyabutr C
Dermatitis; 2022 Mar-Apr 01; 33(2):116-121. PubMed ID: 34570734
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Patch Test Findings in Patients With Anogenital Dermatitis.
Warshaw EM; Kimyon RS; Silverberg JI; Belsito DV; DeKoven JG; Maibach HI; Zug KA; Atwater AR; Mathias T; Sasseville D; Fowler JF; Marks JG; Reeder MJ; DeLeo VA; Pratt MD; Zirwas MJ; Taylor JS; Fransway AF
JAMA Dermatol; 2020 Jan; 156(1):85-91. PubMed ID: 31774454
[TBL] [Abstract][Full Text] [Related]
15. Shoe allergens: retrospective analysis of cross-sectional data from the north american contact dermatitis group, 2001-2004.
Warshaw EM; Schram SE; Belsito DV; DeLeo VA; Fowler JF; Maibach HI; Marks JG; Mathias CG; Pratt MD; Rietschel RL; Sasseville D; Storrs FJ; Taylor JS; Zug KA
Dermatitis; 2007 Dec; 18(4):191-202. PubMed ID: 18021598
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis.
Kasumagic-Halilovic E; Ovcina-Kurtovic N
Med Arch; 2018 Oct; 72(4):276-279. PubMed ID: 30514994
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001-2016.
Silverberg JI; Hou A; Warshaw EM; Maibach HI; Belsito DV; DeKoven JG; Zug KA; Taylor JS; Sasseville D; Fransway AF; DeLeo VA; Pratt MD; Reeder MJ; Atwater AR; Fowler JF; Zirwas MJ; Marks JG
Arch Dermatol Res; 2022 Nov; 314(9):857-867. PubMed ID: 34748058
[TBL] [Abstract][Full Text] [Related]
18. Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).
Wentworth AB; Yiannias JA; Keeling JH; Hall MR; Camilleri MJ; Drage LA; Torgerson RR; Fett DD; Prakash AV; Scalf LA; Allen EM; Johnson JS; Singh N; Nordberg Linehan DL; Killian JM; Davis MD
J Am Acad Dermatol; 2014 Feb; 70(2):269-75.e4. PubMed ID: 24268786
[TBL] [Abstract][Full Text] [Related]
19. Foot contact dermatitis: nitrofurazone as the main cause in a retrospective, cross-sectional study over a 16-year period from Turkey.
Özkaya E; Polat Ekinci A
Int J Dermatol; 2016 Dec; 55(12):1345-1350. PubMed ID: 27496199
[TBL] [Abstract][Full Text] [Related]
20. A closer look at allergic contact dermatitis caused by topical ophthalmic medications.
Alves PB; Figueiredo AC; Codeço C; Regateiro FS; Gonçalo M
Contact Dermatitis; 2022 Oct; 87(4):331-335. PubMed ID: 35715881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
